Novartis AG (NVS)
NVS Share PerformanceMore
|52 week high||86.90 22/06/17|
|52 week low||69.53 24/01/17|
|52 week change||13.33 (18.72%)|
|4 week volume||24,765,030 18/11/17|
Latest News« previous» nextMore
01/08/2017 - 09:13 Money Observer
Fiona Hamilton runs through the chosen nine conservative investments trusts and how they have performed so far.
27/07/2017 - 12:13 Intreractive Investor
After rejecting a 55 per share bid from Pfizer three years ago, AstraZeneca is now languishing below 43. The pressure's on ...
07/07/2017 - 14:42 Interactive Investor
This week has been dominated by takeover news, leading to some huge gains on the FTSE All-Share. Danny Beddard runs ...
10/11/2016 - 11:20 Interactive Investor
Ceri Jones considers the extent to which the world has become harmonised and accessible for investors over the past 21 yea...
22/08/2016 - 11:48 Interactive Investor
UK dividends lagged rivals in the second quarter and one expert has cut income forecasts for the full-year. Lee Wild repor...
14/03/2016 - 14:17 Money Observer
With advice and fund tips from a panel of experts, we built two solid, inflation-busting portfolios of Rated Funds for an a...
24/02/2016 - 13:15 Interactive Investor
Glaxo's refusal to consider a break-up is frustrating major shareholders. Here's what star fund manager Neil Woodford th...
03/02/2016 - 14:46 Interactive Investor
GlaxoSmithKline received a shot in the arm Wednesday following fourth quarter and full-year results. Here's why.
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment